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Claudin Distributions and Functions in Intestines
Intestinal epithelial integrity is vital for nutrition absorption and 
host defense against pathogens. The gastrointestinal (GI) tract 
can be divided into the small intestine that includes duodenum, 
jejunum and ileum and the large intestine that contains cecum 
and colon. Both intestines share a general structure with four lay-
ers: mucosa, submucosa, muscularis externa and serosa. Intestinal 
epithelium (enterocytes) is in the mucosa layer. Tight junctions 
(TJs) are the most apical structure present in the junctional com-
plex between the epithelial cells. They form a circumferential 
belt around the epithelial sheet, separating the cell membrane 
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Intestines are organs that not only digest food and absorb 
nutrients, but also provide a defense barrier against pathogens 
and noxious agents ingested. Tight junctions (TJs) are the most 
apical component of the junctional complex, providing one 
form of cell-cell adhesion in enterocytes and playing a critical 
role in regulating paracellular barrier permeability. Alteration 
of TJs leads to a number of pathophysiological diseases causing 
malabsorption of nutrition and intestinal structure disruption, 
which may even contribute to systemic organ failure. Claudins 
are the major structural and functional components of TJs 
with at least 24 members in mammals. Claudins have distinct 
charge-selectivity, either by tightening the paracellular 
pathway or functioning as paracellular channels, regulating 
ions and small molecules passing through the paracellular 
pathway. In this review, we have discussed the functions of 
claudin family members, their distribution and localization in 
the intestinal tract of mammals, their alterations in intestine-
related diseases and chemicals/agents that regulate the 
expression and localization of claudins as well as the intestinal 
permeability, which provide a therapeutic view for treating 
intestinal diseases.
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into apical (the side toward the lumen) and basolateral (the side 
facing the extracellular matrix) domains. The permeability of 
TJs varies in different segments of intestines. Well-formed TJs 
are characterized by high transepithelial electrical resistance 
(TER) and low solute permeability. The permeability of TJs can 
be determined by measuring the paracellular fluxes of ions and 
small molecules such as 3H-mannitol and FITC-dextran. The 
permeability of TJs changes under different physiological and 
pathological conditions.
There are three main families of TJ proteins: the claudin fam-
ily, the occludin family and the IgG-like family of junctional 
adhesion molecules (JAMs).1 Claudins are the main determi-
nants of barrier properties of the TJs. Up to now, at least 24 
members of the claudin family have been identified. Claudins are 
transmembrane proteins containing two extracellular domains 
and one intracellular domain with N- and C-termini facing the 
cytoplasm.2 Many claudins have distinct charge-selectivity. Some 
claudins act by plugging the paracellular pathway while others 
function as paracellular channels. For example, claudin-2 and 
-15 are cation-selective while claudin-17 is anion-selective.3 The 
incorporation and association of occludin, claudins and JAMs 
into TJ strands require local clustering of scaffolding proteins, an 
important group of which is ZO proteins, such as ZO-1, ZO-2 
and ZO-3.4
Differential expression patterns of claudin members in the GI 
tract are likely to contribute to local diversity of TER and para-
cellular ion flow. In human, real-time RT-PCR reveals that clau-
din-2 and -15 are predominantly expressed in the proximal parts 
of the GI tract.5 By immunofluorescence staining, claudin-1 is 
expressed and mainly localized at the apex of epithelial cells with 
a typical reticular pattern in the colon.6,7 Claudin-2 is detected in 
both villus and crypt cells of the small intestine but restricted to 
undifferentiated crypt cells in the colon. Claudin-3, -4, -7 and -8 
are predominantly expressed in the distal parts (colon, sigmoid 
and rectum) of the GI tract. Claudin-12 shows an ubiquitous 
expression pattern throughout the entire GI tract.5 Claudin-4 
and -7 are detected in both the lateral membrane of the cell sur-
face and the TJs.8
In mice, mRNAs of claudins 1–5, 7–15, 17 and 18 are all 
detected in GI tract with claudin-2, -3, -7 and -15 being the 
most highly expressed while claudin-1, -5, -9, -10 and -11 being 
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on the crypt side of the FAE compared with stronger expression 
on the crypt side of villous epithelial cells; claudin-3 is found 
throughout the dome of the FAE; claudin-4 is preferentially 
expressed in the apex region of the FAE in mice.15
The expression of claudins also changes during the postnatal 
development. During the development, rodent intestinal barrier 
function matures in the first 3 weeks of life due to the establish-
ment of the intestinal flora. Commensal bacterial colonization 
induces intestinal barrier function maturation by promoting 
claudin-3 expression in mice.16 In mice, by RT-PCR, claudin-19 
is only detected at days 1, 14 and 28. Claudin-2 expression 
decreases continuously from birth to 90 d by 10-fold, while 
claudin-3, -4, -7 and -15 increase in the range of 2- to 20-fold. 
Claudin-1 and -8 fall dramatically after day 1 and claudin-12 
doubles between day 14 and 28 (Fig. 1).9
The rat colon shows the highest epithelial resistance, followed 
by duodenum, jejunum and ileum. Duodenum and colon have 
the strongest expression of “tightening” claudin-1, -3, -4, -5 and 
-8 and the lowest expression of claudins mediating ion perme-
ability, mainly claudin-2, -7 and -12, compared with jejunum 
and ileum.17 Claudin-3, -4 and -5 are all detectable in ileum, but 
only claudin-3 and -5 are detected in jejunum in rats. Claudin-4 
expression is also found in the enteric neurons in rat distal colon.18 
The localization of claudins can be junctional, lateral or show a 
gradient in junctional and/or lateral distribution along the crypt-
to-villus surface axis. Claudin-2 is restricted to crypts in the 
small and large intestines. Claudin-3 localizes both at the TJs 
and the lateral membrane and increases from the crypt to surface 
cells of the colon. Claudin-4 expression is highest in the lateral 
membrane of the villus surface epithelial cells in both the small 
and large intestines. Claudin-5 is strictly located at the junctions 
of both endothelial and epithelial cells and shows no gradation 
along the crypt-to-villus surface axis in any part of the intestines. 
Claudin-2 shows a crypt-to-villus decrease.19
In dogs, there are high expressions of claudin-3 and -5 and 
a weak expression of claudin-7 in the duodenum. In the colon, 
there are high expressions of claudin-2 and -3 and weak expres-
sions of claudin-5 and -7 proteins by western blot. The localiza-
tion detected by immunofluorescence microscopy shows that the 
duodenum and colon have the staining for claudin-3 and -5 in 
the most apical region and claudin-7 in the basolateral region.20
Studies of claudin mutations in humans and gene-knockout 
in mice have revealed specific roles for a number of claudins in 
the TJ barrier function, selective ion permeability, as well as their 
related pathological phenotypes.
Claudin-7 forms a protein complex with claudin-1 and inte-
grin α2 at the basolateral surface in mouse intestines. Knockout 
of claudin-7 in mice (Cldn7−/−) has severe intestinal defects 
weakly expressed.9,10 Both claudin-7 mRNA and protein are 
strongly expressed in the duodenum, jejunum, ileum and colon.11 
Claudin-8 mRNA and protein are moderately expressed in the 
ileum and colon, but were absent in the jejunum and duodenum. 
Claudin-12 mRNA and protein are highly expressed in the ileum 
and are moderately observed in the jejunum and colon and barely 
detected in the duodenum. Claudin-13 mRNA and protein are 
observed in colon, but undetectable in the rest of the intestines. 
The expression of claudin-15 mRNA and protein is high in the 
duodenum and jejunum, but is decreased from the ileum to 
colon.12 Claudin expression profiles in both human and mice are 
shown in Table 1.
In terms of sub-cellular localization, claudin-2 protein is 
localized in the deep crypt of the distal colon while claudin-10 is 
localized in the entire crypt.9 Claudin-7 is expressed along apical 
and basolateral cell surfaces of epithelial cells in small intestines, 
while claudin-8 is distributed on basolateral membranes of epi-
thelial cells in the ileum and colon.11,12 Claudin-12 is localized at 
the apical-most tips of lateral membranes of epithelial cells in the 
jejunum, ileum and colon, but not in the duodenum. Claudin-13 
is distributed at the apical membranes of colonic epithelial cells 
and claudin-15 is localized at the apical membranes of epithelial 
cells in both the small and large intestines.12,13
Peyer’s patches are important sites for mucosal immune 
responses in intestines, and it contains follicle-associated epithe-
lium (FAE) structure. Claudin-1 is detected in the TJs of intesti-
nal lymphoid FAE in mice;14 claudin-2 is only weakly expressed 
Figure 1. Claudin profiling during postnal intestinal development in 
mice (adapted from Holmes et al., 2006).9
Table 1. Expression of claudins in mammalian intestines
Intestine segments Expression of claudins in human References Expression of claudins in mice References
duodenum 1, 2, 3, 4, 5, 7, 12, 15, 5, 79, 80 2, 3, 7, 15 9, 32
jejunum Not determined 5 2, 3, 7, 12, 15 9, 12, 13, 32
ileum 2, 7, 8, 12, 15 5 1, 2, 3, 4, 7, 8, 12, 15 9, 10, 31, 103, 167
Large intestine 1, 3, 4, 7, 8, 12, 15 5, 6, 7, 8 1, 2, 3, 4, 5, 7, 8, 12, 13, 15 9, 32, 41, 47, 49, 77, 96
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in human and mouse. Both Cdx1 and Cdx2 activate the clau-
din-2 promoter in the human intestinal colorectal adenocarci-
noma epithelial cell line Caco-2, which is a widely used model 
for studying the human intestinal barrier. HNF-1α augments the 
Cdx2-induced but not Cdx1-induced transcriptional activation 
of the human claudin-2 promoter.30 Claudin-2 expression in the 
intestine is also regulated by the transcriptional factor GATA-4, 
which is undetectable in the colon.31 Claudin-2, -3, -7 and -15 
have been found to be recruited to the TJs in the mouse intestinal 
epithelial cells by EpCAM. Mutation of EpCAM in mice leads 
to the downregulation of these claudins and the disruption of TJ 
strands.32
Sodium proton exchangers (NHEs) constitute a large family 
of integral membrane protein transporters that are responsible 
for the counter-transport of protons and sodium ions across lipid 
bilayers. Mucosa from Na+/H+ exchanger 2 knockout mice sub-
jected to complete mesenteric ischemia displays a shift of occlu-
din and claudin-1 membrane expression to cytoplasm and shows 
the disruption of occludin and claudin-1 localization patterns 
following injury.33 Expression of claudin-2 may be under the 
regulation of NHE3. Knockout of NHE3 in mice decreases the 
mRNA expression of claudin-2 and -15.34 Aquaporin 3 (AQP3) 
knockdown significantly enhances the paracellular permeability 
and decreases the expression of claudin-1 and occludin by west-
ern blots.35
Protein tyrosine phosphatase, non-receptor type 2 (PTPN2) is 
an inflammatory bowel disease (IBD) candidate gene. Mutation 
of PTPN2 causes IBD. McCole has reported that PTPN2 pro-
tects the epithelial barrier function by restricting the capacity of 
IFN-γ to increase epithelial permeability and prevent the induc-
tion of the pore-forming protein, claudin-2 expression.36 Toll-like 
receptors (TLRs) are a class of proteins that play a key role in the 
innate immune system as well as in the digestive system. TLR2−/− 
mice suffer the impaired epithelial barrier function with colonic 
mucosal ulcerations, bleeding and increased cell death after bac-
terial pathogen Citrobacter rodentium infection compared with 
the wild-type (WT) mice. Claudin-3 is mislocalized in TLR2−/− 
intestine after infection in that it relocates from the normally 
lateral distribution to the cytoplasm in the enterocytes.37 IL-10 
knockout mice (IL-10−/−) exhibit a significant increase in the 
cumulative permeation of mannitol through the colonic mucosa 
and a significant decrease in TER compared with WT mice. 
Histological analysis shows that spontaneous colitis develops in 
all IL-10−/− mice with mucosal ulceration, erosion and neutrophil 
infiltration in the lamina propria. Molecular analysis reveals the 
decreased expression and redistribution of claudin-1, ZO-1 and 
occludin in IL-10−/− mice. Probiotic Lactobacillus plantarum treat-
ment on IL-10−/− mice greatly improves colitis in that the paracel-
lular permeability is reduced and the expression and distribution 
of claudin-1, ZO-1 and occludin is restored in IL-10−/− mice.38
FoxO4 is a member of the forkhead box transcription factor 
O (FoxO) subfamily. FoxO4 inhibits the transcriptional activ-
ity of NF-κB and protects the mice against colonic injury and 
inflammation. FoxO4 deficiency in mice results in an increase 
in intestinal epithelial permeability and the downregulation of 
ZO-1 and claudin-1.39 Guanylyl Cyclase C (GCC) signaling 
resembling inflammatory bowel disease (IBD) syndrome that 
includes mucosal ulcerations, epithelial cell sloughing and inflam-
mation, which lead to the death of the mice. At the molecular 
level, Cldn7−/− intestines produce significantly higher levels of 
cytokines, NF-κB p65 and cyclooxygenase 2 (COX-2) as well as 
matrix metalloproteinase (MMP)-3 and -7.11 Claudin-8 is found 
to be involved in regulating paracellular Na+ permeability, pro-
tecting the leakage of Na+ into the intestinal lumen.21 Claudin-2 
and -12 contribute to Ca2+ absorption in intestinal epithelial 
cells. The expression of claudin-2 and -12 could be induced by 
an active form of vitamin D
3
, 1α, 25-dihydroxyvitamin D
3
.22,23 
The small intestine is responsible for nutrient absorption and 
the absorption of monosacchrides, amino acids and vitamin C 
is coupled directly to Na+ absorption. It has been reported that 
claudin-15 knockout mice are born and grow normally but with 
an enlarged upper small intestinal phenotype, megaintestine, 
in that the upper small intestine is approximately 2 times larger 
than normal in length and diameter. Knockout of claudin-15 
does not alter the expression of other types of claudins, such as 
claudin-1, -2, -3, -4, -7, -12, -18, -20 and -23.24 Double knockout 
of claudin-2 and -15 reduces the paracellular flow of Na+ from 
intestinal submucosa into the lumen and decreases the absorp-
tion of glucose, amino acids and fats, thus leads to the malnutri-
tion and death of the mice 25 d after birth.25 Claudin-16 may be 
responsible for the defective absorption of Ca2+ in the intestines 
causing primary hypercalciuria.26
The function of claudins in intestines just begins to be unrav-
eled in recently years. It is expected that new discovery will be 
made when more claudin-specific gene deletion models become 
available in the near future.
Regulation of Claudin Expressions in Intestines
The expression levels of claudins in intestines are under the 
regulation of a number of genes and/or proteins. Cathepsin L 
belongs to the cysteine protease class of the papain superfamily 
that is involved in intracellular and extracellular protein degrada-
tions. Inhibition of intracellular cathepsin L activity results in a 
rapid upregulation of claudin-1 protein accumulation in IEC-6/
Cdx2L1 cell line, an epithelial cell line conditionally expressing 
Cdx2, a transcription factor that initiates intestinal epithelial 
differentiation. Mutant mice defective in cathepsin L activity 
display an elevated level of intestinal claudin-1 and -2 expres-
sion, which may be responsible for the intestinal neoplasia in 
mice.27 Claudin-1 gene is also under the regulation of β-catenin. 
Claudin-1 expression decreases significantly in response to the 
reduction of β-catenin in intestines.28 The trefoil factor family 
3 (TFF3) plays an important role in the protection and repair 
of the GI mucosa. Overexpression of TFF3 in HT29/B6 cells, 
a human colon carcinoma cell line, increases the cellular level 
of claudin-1 and decreases the amount of claudin-2 accompa-
nied by an increase in the TER in confluent monolayers of these 
cells.29 Claudin-2 expression is under the positive regulation of 
Cdx2.30 The 5'-flanking region of the claudin-2 gene contains 
binding sites for intestine-specific Cdx homeodomain proteins 
and hepatocyte nuclear factor (HNF)-1, which are conserved 
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effective regulators of claudin genes/proteins is an ongoing task 
and has high clinical relevance.
Claudins are Modulated in the Disease State  
of Intestines
The intestinal barrier plays a critical role in the transport of nutri-
ents and macromolecules. At the same time, it has to provide 
an effective barrier to harmful macromolecules and microorgan-
isms.55 Defects in this barrier function have been observed in 
intestinal disorders, such as IBD that includes ulcerative colitis 
(UC) and Crohn disease (CD), food allergies and celiac diseases. 
TJs are essential components of the physical intercellular barrier 
that separates and prevents the mixing of luminal contents with 
the abdomen. Compromised epithelial barrier function and TJ 
alterations are hallmarks of a number of GI disorders. Luminal 
antigen uptake occurs via TJ discontinuities and epithelial gross 
lesions, which is likely to induce many other changes to the epi-
thelium besides simply TJ barrier alterations.
In IBD, epithelial barrier function is impaired, which contrib-
utes to diarrhea by a leak flux mechanism and triggers inflam-
mation by an increased luminal antigen uptake. Studies show 
that claudin-1 protein expression is significantly reduced in IBD 
patients and its expression is correlated with the duration of the 
IBD symptoms.56 Further studies reveal that the expression of 
claudin-1 is downregulated in epithelial cells immediately adja-
cent to transmigrating neutrophils in IBD.57 The localization of 
claudin-1 is also irregularly distributed and disappeared from 
intercellular junctions in the samples from irritable bowel syn-
drome (IBS) patients.6 There are conflicts on the expression levels 
of claudin-3 and -4 in IBD patients. Claudin-3 and -4 are pres-
ent throughout normal colonic epithelium, but are unchanged, 
reduced or redistributed in the disease surface epithelium.58 Some 
studies show reduced expression of claudin-3 with no changes 
in claudin-4 expression,59 while others report stable claudin-3 
expression with reduced claudin-4 expression at protein lev-
els,8,60 or without any changes,58,61 or changes only in the cellular 
localization.58 IBD-associated diarrhea may result from NF-κB-
mediated TJ proteins occludin, claudin-1 and ZO-1 internaliza-
tion, thus increasing the paracellular permeability.62 Disruption 
of the epithelial barrier is also associated with the internalization 
of claudin-4 to a sub-apical cytoplasmic compartment.56
is a critical mediator of intestinal fluid homeostasis. Knockout 
of GCC in mice results in increased intestinal permeability. 
Claudin-2 expression is found to be reduced in GCC deficient 
intestine.40 Lin et al. have reported that mice deficient in GCC 
exhibits the intestinal barrier hyper-permeability associated with 
the reduced junctional proteins occludin and claudin-4. The 
same observation is also found in Caco-2 cells. This regulation is 
possibly through the upregulation of AKT1 pathway. Restoration 
of occludin and claudin-4 is associated with the reconstitution 
of intestinal barrier integrity by reducing AKT1 expression in 
GCC knockout mice.41 Claudin-1 and -4 can be phosphorylated 
by PKCθ and they can also form endogenous complexes with 
PKCθ, which has the stabilizing effect on the monolayer barrier 
dynamics in Caco-2 cells.42
Loss of smad5 leads to the de-regulation of claudin-1 and -2 
expression in intestines.43 Knockdown of PTEN significantly 
inhibits the polarization, functional differentiation and brush 
border development in Caco-2/15 cells, a stable clone of the par-
ent Caco-2 cells. A strong reduction in claudin-1, -3, -4 and -8 is 
also observed in addition to a decrease in TER.44,45 Claudin-4 has 
been found to be associated with cellular prion protein (PrP(c)) 
that is located at cell-cell junctions. Knockout of PrP(c) in mice 
greatly increases the paracellular permeability. Knockdown of 
PrP(c) in Caco-2/TC7 enterocytes, a stable clone of the parent 
Caco-2 cells, decreases the expression of claudin-4, as well as 
other TJ proteins, such as occludin, ZO-1 and tricellulin at cell 
contacts.46 The protein C (PC) pathway is a well-characterized 
coagulation system. PC deficient mice develop spontaneous 
intestinal inflammation and show increased intestinal perme-
ability. Structural analysis of epithelial TJ molecules reveals that 
lack of PC leads to decreased JAM-A and claudin-3 expression 
and altered pattern of ZO-1 expression.47 Knockout of COX-2 
significantly increases epithelial permeability and reduces the 
expression of claudin-1, ZO-1 and occludin in the ileum follow-
ing cecal ligation and puncture in mice.48 The TJ-associated gene 
claudin-10 is upregulated, whereas claudin-1 and -5 are downreg-
ulated in Mucin Muc2 knockout mice compared with the WT.49
Claudin expression levels are also under the regulation of 
other proteins, such as desmoglein 2,50 matriptase,51 connexin 
26,52 suppression of tumorigenicity-14 (ST14),53 and JAM-A.54 
Proteins and their regulatory effect on the expression of clau-
dins in intestines are summarized in Table 2. The search for the 
Table 2. Regulation of claudin expression in intestines by transcription factors or other protein modulators
Claudin Transcription factors Other protein modulators References
1
β-catenin, Trefoil factor family 3, FoxO4, 
Smad5, COX-2
Cathepsin L, Na+/H+ exchanger 2, Aquaporin 3, IL-10, Muc2
27, 28, 29, 33, 35, 38, 39, 43, 
48, 49
2
Trefoil factor family 3, Cdx1, Cdx2, HNF-
1α, GATA-4, Smad5
Cathepsin L, Na+/H+ exchanger 3, EpCAM, PTPN2, Guanylyl 
cyclase C, Matriptase, ST14
27, 29, 30, 31, 32, 34, 36, 40, 43, 
51, 53
3 __ EpCAM, TLR2 32, 37
4 TGF-β Guanylyl cyclase C, PrP(c), Connexin 26 41, 46, 52, 175
5 __ Muc2 49
7 __ EpCAM 32
10 __ Muc2, JAM-A 49, 54
15 __ EpCAM, Na+/H+ exchanger 3, JAM-A 32, 34, 54
www.landesbioscience.com Tissue Barriers e24978-5
dinitrobenzenesulfonic acid (DNBS)-induced colitis in mice.75 
The 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced 
colitic rats show damaged intestinal mucosa and decreased 
expression of claudin-1, -3, -5 and -8 in TJ membrane fractions. 
The n-3 polyunsaturated fatty acids (PUFAs) can prevent the 
redistribution of these TJ proteins and elevate the expression of 
claudin-1, -5 and -8.76 DSS-treated mice/rats show colitis-like 
syndrome with inflammatory response and mucosal damage and 
are often used as a model to study IBD. Immunohistochemistry 
staining as well as western blots show the decreased signals of 
colonic claudin-1, -3, -5, -7 and -8 after DSS treatment in mice, 
while claudin-2 expression is significantly increased after DSS 
treatment. These changes are restored and the intestinal damage 
is attenuated after AMD3100 treatment. AMD3100 is a CXCR4 
antagonist. CXCR4 is constitutively expressed in intestinal epi-
thelial cells and its expression is increased in the specimens of UC 
patients.77 SAMP1/YitFc (SAMP) mouse strain is a spontaneous 
model of IBD, closely resembling CD. SAMP mice show the dis-
rupted barrier function accompanied by the aberrant expression 
of claudin-2 and occludin.78
Gluten-intolerant diseases include celiac disease and gluten-
sensitive disease. Celiac disease is an autoimmune enteropathy 
triggered by the ingestion of gluten. Gluten-sensitive individu-
als develop GI symptoms similar to those in celiac disease, but 
the overall clinical symptom is generally less severe. Gluten-
sensitivity displays significantly reduced intestinal permeabil-
ity and significantly increased expression of claudin-4 at the 
mRNA level compared with the healthy controls in adults.79 
Biopsies from proximal and distal parts of duodenum from chil-
dren with celiac disease show that claudin-2 and -3 expression 
are significantly increased in the severe form of celiac disease in 
bulb and in distal duodenum in comparison to controls, which 
may be, at least in part, responsible for increased permeability 
observed in celiac disease patients.80 In celiac disease patients, 
pore-forming claudin-2 and -15 are upregulated and the tight-
ening claudin-3, -5 and -7 and occludin are downregulated by 
western blot.81 Patients with refractory celiac disease unrespon-
sive to the treatments show increased expression of claudin-4 and 
-5 and decreased expression of pore-forming claudin-2.82 Recent 
studies have indicated that schizophrenia may be also related to 
the celiac disease in that the celiac disease causes an alteration of 
gut permeability that may allow the exogenous psychosis-causing 
substances to enter the body thus causing the development of 
schizophrenia and other mental conditions.83 Collagenous colitis 
is an inflammatory disease of unknown etiology with diarrhea as 
the leading symptom. A pronounced decrease in NaCl absorp-
tion is observed in collagenous colitis, which may be due to the 
downregulation of occludin and claudin-4.60
Besides IBD, there are a number of diseases that have been 
found to be related to intestinal dysfunction. The in vitro cul-
ture model of distal duodenum biopsies from nine patients with 
food allergy is established to study the food allergy. Peptic-tryptic 
digest of wheat gliadin, wheat albumins and apple proteins are 
applied on the culture of biopsy tissues to induce food allergy. 
For the allergic tissues, after exposure to food allergens, clau-
din-1 expression appears to be reduced and exhibits breaks at the 
Epithelial barrier function is impaired in UC. Claudin-2 is 
undetectable in normal colon, but it is strongly expressed along 
the inflamed crypt epithelium. A 956 ± 252% increase in clau-
din-2 expression is observed in mucosal biopsy specimens from 
human patients with UC.63 Mennigen et al. have demonstrated 
that expressions of claudin-1, -3, -4 and -5 are all decreased in 
acute colitis.64 Urinary claudin-3 can be used as an early noninva-
sive diagnostic marker for intestinal TJ loss. It is correlated with 
reduced claudin-3 staining in colonic tissues from biopsies.65 T 
helper (Th) 2 cytokines, such as interleukin (IL)-13 and tumor 
necrosis factor (TNF)-α, are important factors in UC. IL-6, 
a pleiotropic cytokine, is elevated in IBD patients. IL-6 treat-
ment increases TJ permeability by stimulating the expression of 
channel-forming claudin-2 in intestinal epithelial Caco-2 cells.66 
IL-13 stimulates epithelial apoptosis as well as upregulates clau-
din-2 in UC.67,68 This activation is through the signal transducer 
and activator of transcription 6 (STAT6) pathway.69 Myosin 
light-chain kinase (MLCK) activation that is often observed in 
IBD patients can also trigger claudin-2 synthesis and increase 
paracellular cation flux.70 Claudin-7 is detected in both the lateral 
membrane of the cell surface and the TJs by immunofluorescence 
staining and its signal is decreased in active UC biopsies collected 
from the rectum of patients. Downregulation of claudin-7 may 
lead to an altered TJ structure and thus the impaired epithelial 
function in active UC.8 Chronic inflammation in mucosal tissues 
can influence the epithelial barrier function via pro-inflamma-
tory cytokines such as interferon (IFN)-γ and TNF-α. IFN-γ 
induces a time-dependent increase in paracellular permeability 
that is associated with the internalization of claudin-1, occludin 
and JAM-A.71
The epithelium in inflamed intestinal segments of patients 
with CD is characterized by a reduction of TJ strands, strand 
breaks and alterations of TJ protein content and composition.72 
CD patients show significantly increased intestinal permeability. 
In the intestines of patients with active CD, freeze fracture elec-
tron microscopic analysis reveals that occludin and the sealing 
TJ proteins claudin-5 and -8 are all downregulated and redistrib-
uted off the TJ, whereas the pore-forming TJ protein claudin-2 is 
strongly upregulated, which constitute the molecular basis of TJ 
changes.59 Das et al. have also reported that claudin-4, -5 and -8 
are redistributed from the TJ to the subjunctional lateral mem-
brane in CD patients.73
The mRNA of claudin-12 is significantly upregulated in the 
ileum of CD patients while the claudin-2 mRNA is significantly 
reduced by 5-fold in the sigmoid colon compared with healthy 
controls. The mRNA expression levels of claudin-12 and -4 are 
significantly downregulated in CD patients in the colon com-
pared with the nearby unaffected tissue. Although significant 
differences are not observed, there is a trend of downregulation 
of claudin-3 in the colon of CD patients.5 Portitz et al. have 
reported an increase of claudin-1 in human UC specimens and 
unchanged claudin-1 expression in CD patients. Thus it is sug-
gested that claudin-1 may be used to differentiate between UC 
and CD cases.74
Various animal models are established to study the mecha-
nisms causing IBD. An upregulation of claudin-2 is observed in 
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expression of claudin-4 in the duodenum.91 Strangulated intesti-
nal obstruction (STR-IO) patients show increased expression lev-
els of ZO-1, occludin and claudin-1 at both mRNA and protein 
levels in the colonic tissues.7 Chronic metabolic acidosis (CMA) 
enhances the mRNA expressions of claudin-2, -3, -6, -8, -11, -12, 
-14, -19 and -22 in Sprague-Dawley rats with chronic metabolic 
acidosis induced by NH
4
Cl.92,93 Hemorrhagic shock (HS) leads to 
the intestinal barrier loss as well as the loss of claudin-3 and ZO-1 
in rats.94 Beutheu et al. have shown that claudin-1 and occludin 
expression levels are reduced during the acute phase of mucosi-
tis compared with control rats. During the recovery phase, their 
expression levels are restored.95 Wang et al. have reported that 
the side-stream smoking increases mouse intestinal bacteria and 
upregulates the expression of claudin-3 and ZO-2 in mouse large 
intestine.96
The intestinal epithelial barrier function is often disrupted 
in many surgical diseases, including trauma, shock, burn injury 
and the other surgically critical illness, resulting in the increased 
intestinal permeability and subsequent translocation of bacte-
ria and/or endotoxin from the GI tract.97,98 Intestinal surgical 
trauma can transiently compromise the protein levels of clau-
din-1 and E-cadherin in intestines.99 Ischemia/reperfusion (I/R) 
injury of the intestine is the leading cause of organ dysfunction 
after restoration of blood flow in many diverse events, including 
shock and intestinal transplantation. I/R injury can cause intes-
tinal mucosal lesions in rats and redistribute occludin, ZO-1, 
claudin-1 and -3 from the cell membrane to the cytoplasm in 
intestinal epithelial cells as shown by immunofluorescent micros-
copy.100 In addition, mRNA expression levels of claudin-1 and -7 
are significantly decreased from the beginning of reperfusion and 
are recovered to the control level by 24 h. On the other hand, 
claudin-4 mRNA expression level is significantly increased from 
the start of the reperfusion and then reaches to the control level 
24 h after reperfusion. The protein expression levels of claudin-1, 
-2, -4 and -7 are significantly decreased until 1 h after reper-
fusion.101 The expression level of nitric oxide (NO) is increased 
during intestinal I/R. NO participates in opening TJ by down-
regulating the protein expression of claudin-1, -2, -4 and -7.102
Claudin-1 is predominantly localized in the cytoplasm of the 
ileum in mice, and its expression is markedly elevated in cyto-
plasm following burn injury, which may contribute to the histo-
logical damage of intestinal mucosa after burn injury.103 EtOH 
combined with burn injury results in no change of claudin-1 
protein content but its phosphorylation on tyrosine is decreased 
following EtOH and burn injury.104 Table 3 summarizes the 
changes of claudin expression in intestines in currently known 
disease status. We conclude that the majority of the claudins are 
downregulated in the disease with only pore-forming claudin-2 
being consistently upregulated in several diseases.
Claudins and Colorectal Cancer
The function of TJ proteins is compromised not only in a num-
ber of intestinal diseases but also in colorectal cancer. Claudin-1 
is weakly expressed at the apical boarder of the lateral mem-
brane of normal enterocytes, but is strongly expressed at cell-cell 
cell-cell regions.84 Acute pancreatitis can induce intestinal injury 
and reduce the expression of claudin-1 at both mRNA and protein 
levels in the intestinal tissues. Studies of colonic biopsies indicate 
that both minimized and conventional cardiopulmonary bypass 
procedures cause moderate mucosal damage, an increase in epi-
thelial cell proliferation and a decrease in expression of TJ protein 
claudin-4.85 Other diseases, such as uremia and chronic kidney 
disease (CKD) can affect intestinal barrier function and cause sys-
temic inflammation. CKD greatly reduces the protein expressions 
of claudin-1, occludin and ZO-1 in the colonic mucosa, showing 
the thickened colonic wall and heavy infiltration of mononuclear 
leukocytes in the intestinal lamina propria.86 Patients with liver 
cirrhosis show the intestinal barrier dysfunction and hyperperme-
ability. Assimakopoulos et al. have recently reported that liver cir-
rhosis patients show significantly reduced expression of occludin 
and claudin-1 in duodenum as compared with healthy controls by 
immunohistochemical analysis. As a result, liver cirrhosis patients 
present significantly higher endotoxin values in peripheral blood 
as compared with healthy controls. Disruption of TJs could be 
due to the cytokine secretion, such as TNF-α and IFN-γ, in 
cirrhosis patients.87 Iron can be toxic to the intestines in that it 
increases cell monolayer permeability and causes partial delocal-
ization of claudin-4 from the plasma membrane to an intracellular 
compartment.88 Expression of claudin-2 is induced by iron-defi-
ciency in rats’ duodenum.89 High fat diet is also shown to increase 
small intestinal permeability that is possibly due to decreases in 
claudin-1, claudin-3 and occludin expression in the small intes-
tine.90 Intestinal hyper-permeability is often seen in patients with 
obstructive jaundice. Occludin, claudin-1 and -7 are significantly 
decreased whereas claudin-4 is significantly increased in jaundiced 
patients and their distributions are altered as well. Patients with 
malignant obstructive jaundice show loose microvillus and wider 
cell junctions with reduced expression of claudin-1 and increased 
Table 3. Changes in claudin expression in intestines in diseases
Diseases Changes of claudin(s) References
inflammatory bowel disease 1 ↓ 56, 57
ulcerative colitis 2 ↑, 7 ↓ 8, 63
acute colitis 1 ↓, 3 ↓, 4 ↓, 5 ↓ 64
Crohn’s disease 2 ↑↓, 4 ↓, 5 ↓, 8 ↓, 12 ↑↓ 5, 59
gluten-sensitive disease 4 ↑ 79
celiac disease 2 ↑, 3 ↓↑, 5 ↓, 7 ↓, 15 ↑ 80, 81
collagenous colitis 4 ↓ 60
food allergy 1 ↓ 84
acute pancreatitis 1 ↓, 4 ↓ 85
chronic kidney disease 1 ↓ 86
liver cirrhosis 1 ↓ 87
obstructive jaundice 1 ↓, 4 ↑, 7 ↓ 91
strangulated intestinal 
obstruction
1 ↑ 7
ischemia/reperfusion injury 1 ↑, 4 ↑, 7 ↓ 101
burn injury 1 ↑ 103
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is progressively increased within the cytoplasm. Quantitative 
real-time PCR shows that EHEC alters the mRNA transcrip-
tion of claudin-2 and -3. Most notably, claudin-2 expression is 
significantly increased, which correlates with increased intestinal 
permeability.118
Yersinia enterocolitica is a common cause of acute gastroenteri-
tis. Exposure of human colonic HT-29/B6 cells to Y. enteroco-
litica results in a decrease in TER. After infection, claudin-3, -4 
and -8 are redistributed from TJ into the cytoplasm. In addition, 
the expression of claudin-2, -3, -8, -10 and ZO-1 is diminished 
by western blot analysis.119
Campylobacter jejuni is a leading cause of human enterocolitis. 
Infection of polarized T84 monolayers with C. jejuni causes a 
time-dependent decrease in TER. Lipid rafts are submembrane 
domains that are preferentially partitioned in the apical mem-
brane of polarized epithelium. The loss of TJ barrier function 
has been correlated with translocation of lipid raft-associated 
TJ proteins.120 In the uninfected control T84 cells, the majority 
of claudin-1 is found in lipid rafts. Upon infection, T84 cells 
exhibit a concomitant increase in raft-associated claudin-1.121 
Infection of HT-29/B6 cells with bacteria strains Campylobacter 
concisus impairs the epithelial barrier function characterized by a 
time- and dose-dependent decrease in TER. The expression level 
of barrier-forming TJ protein claudin-5 is only 66 ± 8% at the 
protein level and 49 ± 16% at the mRNA level compared with 
the control cells after infection. However, there is no distribution 
change of claudin-5 observed.122
Humen et al. have reported recently that Giardia intestina-
lis trophozoite promotes an adhesion-dependent decrease in TER 
accompanied by a rearrangement of functional TJ-associated 
occludin and delocalization of claudin-1 in human intestinal 
Caco-2/TC7 cells.123 Entamoeba histolytica produces and secretes 
Prostaglandin E(2) (PGE(2)), an inflammatory molecule that 
decreases barrier integrity of TJs. Loss of mucosal barrier integ-
rity corresponds with the increased Na+ permeability across 
TJs. PGE(2) also dissociates claudin-4 from cell membrane to 
cytoplasm.124
Bifidobacterium bifidum improves the intestinal integrity in a 
rat model of necrotizing enterocolitis. Asphyxia and cold stress 
are applied to the premature newborn rats to induce neona-
tal necrotizing enterocolitis (NEC). Claudin-3 is significantly 
increased in NEC rats and is localized mainly in the cytoplasm 
of the enterocytes. Administration of probiotic B. bifidum nor-
malizes the expression and localization of claudin-3 in the ileum 
compared with the control animals with NEC, thus it protects 
against NEC in the neonatal rat model.125 Bifidobacterium infan-
tis culture media increase TER and the expression of occludin 
and ZO-1 while decreasing claudin-2 in T84 cells.126
Lactobacillus plantarum inhibits the intestinal epithelial bar-
rier dysfunction induced by unconjugated bilirubin (UCB). High 
concentrations of UCB cause cytotoxicity and decrease the TER 
of the Caco-2 cell monolayer. UCB treatment results in a loss of 
claudin-1 and -4 from the cell membrane as revealed by immuno-
fluorescence microscopy. Both protein and mRNA levels of clau-
din-1 and -4 are reduced in UCB-treated cells as compared with 
the control cells. Probiotic L. plantarum exerts a protective effect 
boundaries as well as in the cytoplasm of colorectal cancer cells.28 
Huo et al. have also indicated that the expression of claudin-1 at 
the mRNA and protein levels is found to be increased in colorec-
tal cancer tissue in comparison to that in the normal tissue speci-
mens. The mRNA level of claudin-1 is correlated with tumor 
depth. Claudin-1 protein may therefore be one of the major fac-
tors involved in colorectal tumorigenesis.105 The increased expres-
sion of claudin-2 may participate in colorectal carcinogenesis.106 
Claudin-3 is overexpressed in human cancerous colorectal tis-
sues and may be used as a biomarker to differentiate cancerous 
colorectal tissues from normal colorectal tissues.107 Using tissue 
biopsy samples, Mees et al. have also found that colorectal car-
cinoma in human exhibits significantly elevated expression levels 
of claudin-1, -3, -4 compared with normal mucosa, which sug-
gests that these proteins may be potential markers for diagnos-
ing colorectal carcinoma.108 Claudin-7 overexpression is found 
in colorectal cancer. Its overexpression is under the regulation 
of Tcf-4 and Sox-9.109 Claudin-8 is downregulated in colorectal 
adenoma samples compared with the normal intestinal tissues.110 
Plasma markers for enterocyte damage (I-FABP, I-BABP) and 
urinary presence of TJ protein claudin-3 can be used to assess the 
gut mucosal barrier.111
Effects of Bacteria/Viruses on Claudin-Mediated 
Intestinal Functions
A number of bacteria and viruses can cause the infection of intes-
tines and alter the intestinal permeability. While some of the 
bacteria have beneficial effects to the intestines, it has been recog-
nized that bacteria and/or endotoxin translocation and increased 
gut permeability play a very important role in the setting of severe 
complications such as systemic inflammatory response syndrome, 
sepsis, multiple organ dysfunction syndrome and multiple organ 
failure.112,113
It is known that Enteropathogenic Escherichia coli (EPEC) 
infection disrupts TJs in mice. Occludin and claudin-1 are dis-
placed from TJ membrane microdomains to cytoplasm after 
EPEC infection using sucrose density gradient centrifugation 
and western blot analysis.114 It has been reported that the micro 
integral membrane protein (MIMP) can protect the intestinal 
barrier from injury by EPEC infection since MIMP-expressing 
NCM460 epithelial cells (NCM460/MIMP) show significantly 
higher immunostaining signals of occludin, claudin-1, JAM-1 
and ZO-1 compared with parental NCM460 cells.115 The asso-
ciations between ZO-1, occludin and claudin-1 are progressively 
decreased after EPEC infection in human intestinal epithelial 
T84 cells, resulting in a loss of barrier function.116
Enteroaggregative Escherichia coli (EAEC)-infected T84 cells 
exhibit irregular shapes and some cells become elongated and/or 
enlarged. Infection of EAEC on intestinal T84 cells also induces 
a decrease in TER and dissociation of claudin-1 from the TJs.117
Enterohemorrhagic Escherichia coli (EHEC) infection leads 
to microvillous effacement of mouse colonocytes. EHEC infec-
tion results in the alteration of TJ proteins claudin-2 and -3. 
After infection, claudin-3 immunostaining is clearly dimin-
ished from the lateral membranes. However, claudin-2 staining 
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downregulation of TJ protein claudin-1 and ZO-1 expression, 
shifts their localization from the cell membrane to cytoplasm and 
reduces TER in Caco-2 cells. Intestinal trefoil factor (ITF) can 
suppress PAF-induced downregulation of TJ proteins and inhibit 
the abnormal localization and distribution of claudin-1 and 
ZO-1.137 Mycotoxin ochratoxin A is able to disrupt the barrier 
function of Caco-2 cells by removal of claudin-3 and -4 from the 
cell membrane.138 Deoxynivalenol (DON) is a mycotoxin that 
often appears on cereals used for human and animal nutrition. 
Using porcine intestinal epithelial cell line (IPEC-J2) as a model, 
the integrity of cell connections is disrupted as measured by TER, 
and the expression of ZO-1 and claudin-3 is reduced when DON 
is applied to the basolateral side of the cells. Interestingly, there 
is no effect of DON on the IPEC-J2 when it is applied to the 
apical side.139 DON also contributes to the loss of barrier func-
tion of porcine intestinal epithelial cell line (IPEC-1) through 
the decreased expression of claudin-4 protein, which is involved 
in the maintenance of the intestinal epithelial cell barrier func-
tion. DON-induced impairment of intestinal barrier is through 
the activation of ERK/MAPK signaling pathway. Inhibition of 
ERK/MAPK pathway restores the intestinal expression of clau-
din-4 protein.140 DON increases the paracellular permeability of 
Caco-2 cell monolayers. This may be through its protein synthe-
sis inhibition role by diminishing the synthesis of claudin-4.141 
Irinotecan causes disorders in the intestinal epithelial barrier 
and induces bacterial translocation. Claudin-1 mRNA in the 
small intestine is significantly decreased and claudin-1 protein 
expression in both the small and large intestines is significantly 
reduced after application of irinotecan.142 Endocannabinoids 
decreases the mRNA of claudin-1 in Caco-2 cells.143 Exposure 
to phenol results in decreased TER and increased paracellular 
flux of FITC-dextran. Delocalization of claudin-1 and ZO-1 
from TJs to cytosol correlates with the permeability increase 
after phenol treatment.144 Prolactin (PRL) can enhance intestinal 
absorption of Ca2+ and other minerals for fetal development and 
milk production. PRL markedly stimulates the transcellular and 
paracellular Ca2+ transport in the duodenum of pregnant and 
lactating rats as well as in Caco-2 cell monolayers. Claudin-15, 
which regulates the epithelial cation selectivity and paracellular 
Ca2+ movement, is required for this PRL-enhanced paracellu-
lar transport.145 PRL is found to downregulate the expression of 
claudin-3 and occludin in IEC-6 crypt cells, a rat small intestine 
epithelial cell line.146 Cofilin is an actin binding protein and its 
dephosphorylation corresponds to the TJ opening, TER decrease 
and claudin-1 dissociation from the cytoskeleton. This suggests 
that cofilin may serve as a target for TJ permeability regulation 
in epithelial cells.147 Phosphatidylethanol is produced from etha-
nol by phospholipase D. It is accumulated after chronic ethanol 
exposure, which induces claudin-1 endocytosis and disrupts the 
claudin-1/ZO-1 association.148
Oxidative stress can cause the increased colonic epithelial 
permeability. For example, hydrogen peroxide (H
2
O
2
) treatment 
changes the localization of claudin-4 from apical TJ to lateral 
membrane in Caco-2 cells.149 Interestingly, incubation of T84 
cells with IL-4 leads to an increased claudin-2 expression with 
a corresponding decrease in TER and increase in permeability 
against UCB damage to Caco-2 monolayer cells, and it restores 
the structure and distribution of TJ proteins and increases the 
mRNA and protein levels of claudin-1 and -4.127 L. plantarum also 
prevents the reduced expression and rearrangement of claudin-1, 
occludin, JAM-1 and ZO-1 proteins induced by enteroinvasive 
Escherichia coli (EIEC) infection in Caco-2 cells.128
Salmonella typhimurium regulates the distribution of clau-
din-1 from the Triton X-100-insoluble fractions to the Triton 
X-100-soluble fractions. Infection with S. typhimurium is associ-
ated with the rapid targeting of TJ complex and loss of barrier 
function. These events result in the enhanced bacterial translo-
cation and initiation of polymorphonuclear leukocyte (PMN) 
migration across the intestinal barrier.129 Analysis of duodenal 
biopsy specimens from patients with chronic giardiasis Giardia 
lamblia infection shows the downregulation of claudin-1 and 
increased epithelial apoptosis.130 Shigella flexneri serotype 2a has 
the ability to remove claudin-1 from TJs upon exposure to T84 
cell monolayers.131
The neonatal small intestine is susceptible to the damage by 
endotoxins and LPS is one of the bacteria endotoxins that are 
widely used by researchers to establish the intestine damage 
model. Bacteria endotoxins are the main cause of sepsis, which 
is one of the primary causes of patient death in the intensive care 
units. Significantly damaged intestinal tissues, inflammatory cell 
infiltration and hemorrhage are observed in the sepsis patients. 
During the polymicrobial sepsis, TJ architecture and the pro-
tein redistribution in TJ membrane microdomains are altered.132 
ZO-1 and claudin-2 expressions are lost from the cell membrane, 
and their protein expression levels are decreased after LPS treat-
ment in rats. Carbachol, one of the clinical cholinomimetic 
drugs, decreases the mucosal damage and ameliorates the intes-
tinal epithelial TJ damage induced by LPS in that the gut bar-
rier permeability is reduced, and the ultrastructure disruption of 
TJs is prevented. Carbachol treatment also significantly increases 
ZO-1 and claudin-2 protein expression after LPS administra-
tion.133 Claudin-1, -3, -4, -5 and -8 are present predominantly in 
the microvillous surface and along the lateral membranes of the 
epithelial cells. Polymicrobial sepsis leads to the diffusion and 
loss of these TJ proteins from the lateral cell boundaries in mice. 
However, the expression of claudin-2 is markedly upregulated in 
sepsis by immunofluorescence staining.
Rotavirus infection of Caco-2 cells alters paracellular permea-
bility and causes redistribution of TJ proteins claudin-1, occludin 
and ZO-1. Claudin-1 redistribution is notably apparent at the 
onset of the decline in TER.134 Expression of TJ proteins occlu-
din, claudin-4 and -5 is reduced in duodenum biopsy samples 
from patients with norovirus infection that may lead to epithelial 
barrier dysfunction.135 HIV can also contribute to the impair-
ment of the intestinal barrier in that the pore-forming clau-
din-2 is increased while the expression of the sealing claudin-1 is 
reduced in HIV patients.136
Disruptions of Claudin-Mediated Intestinal Barriers
Many molecules and factors can disrupt intestinal barri-
ers. For examples, platelet-activating factor (PAF) induces 
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Improvements of Intestinal Barrier that Involves 
Claudins
A number of molecules or chemicals have been found to improve 
the intestinal barrier and ameliorate the alteration of claudins in 
pathological status and thus are used to treat the intestinal barrier 
dysfunction.
Moxibustion may relieve colonic epithelial barrier defect by 
upregulating the expression of colonic epithelial occludin, claudin-1 
and ZO-1 proteins and their mRNAs in the cultivated colonic epi-
thelial cells.166 The fish oil supplement in piglets improves intesti-
nal morphology by increasing villus height and intestinal barrier 
function and upregulating intestinal TJ proteins including occlu-
din and claudin-1. Under the inflammatory condition triggered by 
LPS, fish oil could alleviate the LPS-induced intestinal damage.167 
VSL#3, a probiotic mixture, can stimulate the epithelial-derived 
TNF and prevents the onset of ileitis in SAMP mice by decreas-
ing the ileal paracellular permeability through downregulation of 
claudin-2 and upregulation of occludin.168 Butyrate improves the 
barrier function of GI epithelia and has a potential to treat IBD. It 
restores the TJs in IBD patients by downregulating the expression 
of claudin-1 and -2 and upregulating occludin, cingulin, ZO-1 and 
ZO-2.169 Intestinal alkaline phosphatase (IAP) has been found to 
reduce the intestinal injury in a NEC rat model established by LPS 
administration and this effect is dose-dependent.170 Bao et al. have 
reported that herbs-partitioned moxibustion (HPM) and mild-
warm moxibustion (MWM) treatments significantly enhances 
the expression of occludin, claudin-1 and ZO-1 and improves the 
microstructure of the colonic epithelial barrier in a CD rat model 
established by TNBS treatment.171 Recently, Moran et al. have 
found that Glucagon-like peptide-2 (GLP-2), an intestinotrophic 
enteroendocrine peptide, can increase the TER by upregulating 
the protein expression of occludin and ZO-1 in Caco-2 cells.172 
Using the HT-29/B6 cells as a model, Hering et al. assess the 
barrier-protective effects of TGF-β (isoforms 1–3) on intestines. 
TGF-β increases the claudin-4 expression at the transcriptional 
level by binding to the promoter of claudin-4.173 Nicotine treat-
ment on Caco-2 cell monolayers significantly improves TJ integ-
rity as measured by TER and significantly upregulates occludin 
and claudin-1.174 Kaempferol, a natural flavonoid present in fruits, 
vegetables and teas, provides beneficial effects for human health. 
Kaempferol enhances the TJ integrity in Caco-2 cells. The protein 
levels of claudin-1, -3 and -4 on the cell membrane are increased 
during the first 6 or 12 h after kaempferol administration. Confocal 
fluorescent microscopy reveals higher immunofluorescence intensi-
ties for claudin-3 at the intercellular junctions than the untreated 
controls after kaempferol treatment for 6 h.175 Flavonoid querce-
tin enhances epithelial barrier function and increases claudin-4 
expression in Caco-2 cells.176 Methionine-restricted (MR) diet 
in rats results in the improved colonic epithelial barrier function 
compared with the rats on the control diet by altering TJ protein 
composition. MR diet increases TER with concomitant decrease 
in paracellular permeability. RT-PCR and western blot analysis 
show an 80% increase in claudin-3 mRNA and 5-fold increase in 
claudin-3 protein level.177 IL-15 is able to enhance the TJ forma-
tion in intestinal epithelial cells. The recruitment of claudin-1 and 
while the IFN-γ treatment has the opposite effects, leading to 
decreased claudin-2 and increased TER.150 Gliadin is known to 
cause celiac disease. Treatment of gliadin on Caco-2 cells causes 
a reorganization of actin filaments and reduces the expression of 
the TJ protein occludin, claudin-3 and -4. Immunofluorescence 
staining of these TJ proteins reveals a decrease in plasma mem-
brane staining and an increase in punctate, cytosolic staining 
after gliadin treatment.151 Chitosan can transiently and reversibly 
open the TJs between Caco-2 cells, thus enhancing the paracel-
lular permeability. Chitosan treatment induces claudin-4 degra-
dation and redistribution in the cells, leading to the opening of 
TJs. Chitosan could potentially be used to mediate the transepi-
thelial drug delivery.152 Nanoparticle-mediated drug delivery is a 
fast-growing research field. Si-nanowire-coated silica micropar-
ticles alter TJ permeability and decrease the width of ZO-1 and 
claudin-1 at the TJ in Caco-2 cells in culture.153 Vitamin D can 
suppress the expression of claudin-3 and change the permeabil-
ity of the TJs, thus enhancing the paracellular Ca2+ transport.154 
Miltefosine (hexadecylphosphocholine) is the first effective oral 
agent for the treatment of visceral leishmaniasis. Its oral admin-
istration alters the distribution of claudin-1 and translocates it 
from the intercellular junctions to the cytoplasm.155 Glutamine 
deprivation markedly decreases TER and claudin-1 expression.156
Clostridium perfringens enterotoxin (CPE) is responsible for the 
GI symptoms of the second-most-common bacterial food-borne 
illness. On the other hand, CPE is also currently being explored to 
be used as an anti-cancer therapeutic or enhancing drug delivery 
agent.157 C-terminal CPE (C-CPE) can bind and modulate claudin 
structures, thus enhancing mucosal absorption. Members of the 
claudin family can serve as CPE receptors and convey CPE sensi-
tivity. Human claudin-3 and -4 are two functional CPE receptors. 
Recently, claudin-8 and -14 have also been shown to be able to con-
vey the cytotoxic effect of CPE on mammalian intestines although 
the efficiency is 2-to-10-fold less than that of claudin-4. Specific 
residues responsible for modulating the CPE binding activities have 
been identified.157 Binding of C-CPE to claudin-4 enhances jejunal 
absorption of dextran.158 Besides CPE and C-CPE, Matsuhisa et al. 
have developed a C-CPE mutant that has a broad binding speci-
ficity to claudin-1, -2, -4 and -5, which could enhance the jejunal 
absorption of dextran. The C-CPE mutant binder exhibits a more 
potent jejunal absorption-enhancing effect than that of C-CPE.159 
The treatment of non-cytotoxic recombinant CPE variant is able 
to partially inhibit CPE-induced histologic damage, suggesting 
that non-cytotoxic recombinant CPE variants may be useful for 
protecting against some intestinal effects of CPE.160-162 Tyr306 and 
Leu315 are key residues in C-CPE that are involved in the modu-
lation of claudin-4.163,164 Takahashi et al. have reported that the 
C-CPE194 binds to claudin-4 and enhances mucosal absorption. 
Recently, they have created a mutated form of C-CPE194 by sub-
stituting asparagine at position 309 and serine at position 313 with 
alanine, which increases the affinity to claudin-4 by almost 10-fold 
as compared with C-CPE194. Deletion of 10 amino acids in the 
N-terminal domain of the double-alanine-substituted mutant fur-
ther increases the affinity to claudin-4 by nearly 24-fold as com-
pared with C-CPE194. Therefore, these C-CPE mutants may be a 
promising lead for the development of a clinical TJ modulator.165
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chemical agents that regulate the claudins, either by enhancing or 
ameliorating the intestinal permeability, can provide an opportu-
nity for exploring prospective approaches for treating the intesti-
nal diseases or delivering drugs. More studies are needed in order 
to understand whether the changes in claudins are the causes or 
the consequences of the intestinal diseases and the underlying 
mechanisms related to the intestine disorders.
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-2 to the cell membrane are enhanced by IL-15 in the presence of 
IL-2Rβ subunit, a subunit of IL-15 receptor in T84 cells.178 IL-17 
upregulates claudin-1 and -2 at the transcriptional level, which 
induces the formation of TJs in T84 cells.179 As a summary, the 
above several major factors affecting the intestinal barrier by either 
disrupting or improving TJ structure and function have been listed 
in Table 4.
Conclusion
TJs in enterocytes separate the intestinal lumen from the under-
lying tissues, thus maintaining the homeostasis of intestines. 
Claudins are essential components of TJs regulating paracellular 
solute transport. Claudins can alter or be altered by a number 
of signaling molecules/pathways. Abnormal expression and/or 
mis-localization of claudins are associated with various patho-
physiological conditions of intestines. Studying the molecules/
Table 4. Factors affecting claudin expression and intestinal barrier
Factors disrupting intestinal barrier Claudin(s) References Factors improving intestinal barrier Claudin(s) References
platelet-activating factor 1 ↓ 137 intestinal trefoil factor 1 ↑ 137
mycotoxin ochratoxin A 3 ↓, 4 ↓ 138 moxibustion 1 ↑ 166
deoxynivalenol 3 ↓, 4 ↓ 139, 140, 141 fish oil 1 ↑ 167
irinotecan 1 ↓ 142 VSL#3 2 ↑ 168
endocannabinoids 1 ↓ 143 butyrate 1 ↓, 2 ↓ 169
prolactin 3 ↓ 146 intestinal alkaline phosphatase 1 ↑, 3 ↓ 170
interleukin 4 2 ↑ 150 TGF-β 4 ↑ 173
gliadin 3 ↓, 4 ↓ 151 nicotine 1 ↑ 174
chitosan 4 ↓ 152 kaempferol
1 ↑, 3 ↑,
4 ↑
175
vitamin D 3 ↓ 154 flavonoid quercetin 4 ↑ 176
glutamine 1 ↓ 156 interleukin 17 1 ↑, 2 ↑ 179
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